中文
中文
为了病患而驱动的创新
Patient-first cell therapy innovation

2019
  • 0
Zhou Y., Xu H., Wu H., Yu H., Zhou P., Qiu X., Zheng Z., Chen Q., Xu F., Li G., Zhou J., Cheng G., He W., Zou L, Wan Y. (2019) Streamlined Low-Input Transcriptomics through EASY-RNAseq. J Mol Biol. 431(24):5075-5085. (PMID: 31491452)

Zheng M., Zhang X., Zhou Y., Tang J., Han Q., Zhang Y., Ni Q., Chen G., Jia Q., Yu H., Liu S., Robins E., Jiang NJ., Wan Y.*, Li Q.-J. *, Chen Z.-N.*, Zhu P.* (2019) TCR repertoire and CDR3 motif analyses depict the role of αβ T cells in Ankylosing spondylitis. EBioMedicine. (19)30474-8. (*: Corresponding authors, PMCID: PMC6796593)
03.23
2022
来源:
关键词:
相关阅读

Copyright © 2019 竞彩app生物医药科技有限公司

粤竞彩app安备 竞彩app号

粤ICP备20056630号 Powered by vancheer
关于竞彩app
研究与发展
产品及临床
新闻与媒体
竞彩app

Copyright © 2019 竞彩app生物医药科技有限公司

粤竞彩app安备 竞彩app号

粤ICP备20056630号 Powered by vancheer